RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post–marketing services for authorized COVID–19 vaccines [...] Read more »
PRA Health Sciences selected by Maryland State Medical Society to supply remote patient monitoring and telehealth services
RALEIGH, N.C. and BALTIMORE, April 13, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) and the Maryland State Medical Society (MedChi) announced today that Care Innovations, a PRA Health Sciences company, was selected by [...] Read more »
PRA’s remote patient monitoring platform selected by Merck KGaA, Darmstadt, Germany to work in combination with its human growth hormone treatment system
RALEIGH, N.C. , April 07, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today that Merck KGaA, Darmstadt, Germany, known in the United States as EMD Serono, selected PRA's remote patient [...] Read more »
PRA’s Center for Rare Diseases Launches Toolkit to Identify and Mitigate Risks to Rare Disease Clinical Programs
RALEIGH, N.C., March 22, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the launch of its Patient–Centric Trial Development Toolkit, available now to clinical development sponsors focusing on rare [...] Read more »